Huntington's Disease Society of America
- Our Mission
- Our History
- Find your local HDSA Chapter, Affiliate or Regional Office
- Staff directory
- Board of Trustees
- Faces of HD
News & Announcements Archive
- Global Outcomes Data and Possible New Therapies in the Huntington’s Pipeline
- Jang-Ho Cha, MD, PhD Appointed Chairman of the Board of Trustees at the Huntington’s Disease Society of America
- Huntington’s Disease Society of America Awards Additional HD Human Biology Project
- Auspex Press release
- Marathon Team Raises 80K
- CREST-E Phase III Clinical Trial Stopped Early for Lack of Benefit
- HUNTINGTON’S DISEASE SOCIETY OF AMERICA ANNOUNCES 2014 HD HUMAN BIOLOGY PROJECT GRANT RECIPIENTS
- 2CARE HD Clinical Trial Stopped Early for Lack of Benefit
- 2CARE study of coenzyme Q for Huntington's disease ends in disappointment
- HD and HDSA In The News
- HDSA PSA
Huntington’s Disease Society of America Launches First “HD News” App
For Immediate Release
Contact: Christopher Cosentino
Director of Marketing & Communications
Phone: (212) 242-1968 x229
New York, NY (June 2014) – The Huntington’s Disease Society of America (HDSA) announced today the launch of its new Huntington’s disease (HD) news app that is available for all mobile devices. The app was unveiled during the HDSA 29thAnnual Convention in Louisville, Kentucky.
Titled “HD News” and available through iTunes and Google Play, the free app provides up-to-date news and event information from HDSA.org, research summaries from HDBuzz.net, as well as the latest news related to HD drug discovery and development from Science Daily and Medical News Today.
“HD News is one stop shopping for everyone who follows Huntington’s disease science and related news,” said Louise Vetter, CEO of HDSA. “We’re excited to be able to provide the first customized news app for the HD community as we continue to look for new ways of bringing valuable information and support for families affected by Huntington’s disease.”
The app was custom designed for HDSA for Apptomics and made possible by an education grant from Auspex Pharmaceuticals.
Huntington’s disease is a rare, genetic neurodegenerative disease that progressively causes total physical and mental deterioration that begins during an individual’s prime working years. Every individual with HD will ultimately lose the ability to live independently and die from the disease. Currently, there is no cure for HD. Today, 30,000 Americans are known to have HD, and another 250,000 are considered ‘at risk’ of inheriting the disease from an affected parent. Each child of a person with HD has a 50/50 chance of inheriting the fatal gene and everyone who carries the gene will develop the disease.
The Huntington’s Disease Society of America is the premier nonprofit organization dedicated to improving the lives of everyone affected by Huntington’s disease. From community services and education to advocacy and research, HDSA is the world’s leader in providing help for today and hope for tomorrow for people with Huntington’s disease and their families.
To learn more about Huntington’s disease and the work of the Huntington’s Disease Society of America, visit www.hdsa.org or call 1-800-345-HDSA.